Clinical Trials Browser

Pancreatic Adenocarcinoma × Losartan × 90 days × Clear all

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma